  See all
 |
Articles: Neuro/Psych pharmacology |
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Neurology, 11/20/09
Medication use is associated with fatigue in a sample of community-living individuals who have a spinal cord injury: a chart review
Spinal Cord, 11/20/09 Clinical utility of desvenlafaxine 50mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician
Current Medical Research and Opinion, 11/20/09 Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
American Journal of Health-System Pharmacy, 11/20/09 Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs with pimavanserin, a 5-hydroxytryptamine2A receptor inverse agonist
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 
Prior Articles
Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients
Brain Injury, 11/19/09 The effect of statin therapy on the progression of carotid artery stenosis in relation to stenosis severity
Acta Neurologica Scandinavica, 11/19/09 Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study
Clinical Therapeutics, 11/19/09 Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial
Clinical Therapeutics, 11/19/09 Measuring apathy after traumatic brain injury: Psychometric properties of the Apathy Evaluation Scale and the Frontal Systems Behavior Scale
Brain Injury, 11/18/09 Effects of baclofen on motor units paralysed by chronic cervical spinal cord injury
Brain, 11/18/09 Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway
Multiple Sclerosis, 11/18/09 Mitoxantrone: benefits and risks in multiple sclerosis patients
Neurological Sciences, 11/18/09 Levodopa response in early Parkinsons disease
Movement Disorders, 11/18/09 Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09 Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside
Pediatric Blood & Cancer, 11/18/09 Contribution of impaired mobility to patient burden in multiple sclerosis
Current Medical Research and Opinion, 11/18/09 Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion
Current Medical Research and Opinion, 11/18/09
Exclusive Author Commentary A comparison of treatment thresholds in two large Parkinsons disease clinical trial cohorts
Movement Disorders, 11/17/09 Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|
